# Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive

> **NCT01737450** · PHASE2 · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 58 (actual)

## Conditions studied

- Head and Neck Neoplasms
- Neoplasm Metastasis
- Recurrent Disease
- Progressive Disease

## Interventions

- **DRUG:** BKM120

## Key facts

- **NCT ID:** NCT01737450
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2018-09
- **Final completion:** 2019-03
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-06-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737450, "Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01737450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*